BEVATAS
Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
Desi pharma companies top in biosimilars globallyBiosimilars are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drug...
Biocon shares gains on cancer drug launchA biosimilar is a near copy of an original complex biologic drug.
Amul 2.0: What the ongoing change means for the Rs 18,143 crore cooperativeAround 85% of Amul’s membership still comprises small and marginal farmers. For the new emerging lot dairying is a hard-nosed business.
Load More